The Bacterial Origins of the CRISPR Genome-Editing Revolution

Erik J. Sontheimer, Rodolphe Barrangou

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Like most of the tools that enable modern life science research, the recent genome-editing revolution has its biological roots in the world of bacteria and archaea. Clustered, regularly interspaced, short palindromic repeats (CRISPR) loci are found in the genomes of many bacteria and most archaea, and underlie an adaptive immune system that protects the host cell against invasive nucleic acids such as viral genomes. In recent years, engineered versions of these systems have enabled efficient DNA targeting in living cells from dozens of species (including humans and other eukaryotes), and the exploitation of the resulting endogenous DNA repair pathways has provided a route to fast, easy, and affordable genome editing. In only three years after RNA-guided DNA cleavage was first harnessed, the ability to edit genomes via simple, user-defined RNA sequences has already revolutionized nearly all areas of biological science. CRISPR-based technologies are now poised to similarly revolutionize many facets of clinical medicine, and even promise to advance the long-term goal of directly editing genomic sequences of patients with inherited disease. In this review, we describe the biological and mechanistic basis for these remarkable immune systems, and how their engineered derivatives are revolutionizing basic and clinical research.

Original languageEnglish (US)
Pages (from-to)413-424
Number of pages12
JournalHuman Gene Therapy
Volume26
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Biological Science Disciplines
Archaea
Immune System
Genome
Bacteria
DNA Cleavage
Viral Genome
Clinical Medicine
Eukaryota
Research
DNA Repair
Nucleic Acids
RNA
Technology
DNA
Gene Editing

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Sontheimer, Erik J. ; Barrangou, Rodolphe. / The Bacterial Origins of the CRISPR Genome-Editing Revolution. In: Human Gene Therapy. 2015 ; Vol. 26, No. 7. pp. 413-424.
@article{db6e1ca1de4241fe89f9ad562443df31,
title = "The Bacterial Origins of the CRISPR Genome-Editing Revolution",
abstract = "Like most of the tools that enable modern life science research, the recent genome-editing revolution has its biological roots in the world of bacteria and archaea. Clustered, regularly interspaced, short palindromic repeats (CRISPR) loci are found in the genomes of many bacteria and most archaea, and underlie an adaptive immune system that protects the host cell against invasive nucleic acids such as viral genomes. In recent years, engineered versions of these systems have enabled efficient DNA targeting in living cells from dozens of species (including humans and other eukaryotes), and the exploitation of the resulting endogenous DNA repair pathways has provided a route to fast, easy, and affordable genome editing. In only three years after RNA-guided DNA cleavage was first harnessed, the ability to edit genomes via simple, user-defined RNA sequences has already revolutionized nearly all areas of biological science. CRISPR-based technologies are now poised to similarly revolutionize many facets of clinical medicine, and even promise to advance the long-term goal of directly editing genomic sequences of patients with inherited disease. In this review, we describe the biological and mechanistic basis for these remarkable immune systems, and how their engineered derivatives are revolutionizing basic and clinical research.",
author = "Sontheimer, {Erik J.} and Rodolphe Barrangou",
year = "2015",
month = "7",
day = "1",
doi = "10.1089/hum.2015.091",
language = "English (US)",
volume = "26",
pages = "413--424",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

The Bacterial Origins of the CRISPR Genome-Editing Revolution. / Sontheimer, Erik J.; Barrangou, Rodolphe.

In: Human Gene Therapy, Vol. 26, No. 7, 01.07.2015, p. 413-424.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The Bacterial Origins of the CRISPR Genome-Editing Revolution

AU - Sontheimer, Erik J.

AU - Barrangou, Rodolphe

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Like most of the tools that enable modern life science research, the recent genome-editing revolution has its biological roots in the world of bacteria and archaea. Clustered, regularly interspaced, short palindromic repeats (CRISPR) loci are found in the genomes of many bacteria and most archaea, and underlie an adaptive immune system that protects the host cell against invasive nucleic acids such as viral genomes. In recent years, engineered versions of these systems have enabled efficient DNA targeting in living cells from dozens of species (including humans and other eukaryotes), and the exploitation of the resulting endogenous DNA repair pathways has provided a route to fast, easy, and affordable genome editing. In only three years after RNA-guided DNA cleavage was first harnessed, the ability to edit genomes via simple, user-defined RNA sequences has already revolutionized nearly all areas of biological science. CRISPR-based technologies are now poised to similarly revolutionize many facets of clinical medicine, and even promise to advance the long-term goal of directly editing genomic sequences of patients with inherited disease. In this review, we describe the biological and mechanistic basis for these remarkable immune systems, and how their engineered derivatives are revolutionizing basic and clinical research.

AB - Like most of the tools that enable modern life science research, the recent genome-editing revolution has its biological roots in the world of bacteria and archaea. Clustered, regularly interspaced, short palindromic repeats (CRISPR) loci are found in the genomes of many bacteria and most archaea, and underlie an adaptive immune system that protects the host cell against invasive nucleic acids such as viral genomes. In recent years, engineered versions of these systems have enabled efficient DNA targeting in living cells from dozens of species (including humans and other eukaryotes), and the exploitation of the resulting endogenous DNA repair pathways has provided a route to fast, easy, and affordable genome editing. In only three years after RNA-guided DNA cleavage was first harnessed, the ability to edit genomes via simple, user-defined RNA sequences has already revolutionized nearly all areas of biological science. CRISPR-based technologies are now poised to similarly revolutionize many facets of clinical medicine, and even promise to advance the long-term goal of directly editing genomic sequences of patients with inherited disease. In this review, we describe the biological and mechanistic basis for these remarkable immune systems, and how their engineered derivatives are revolutionizing basic and clinical research.

UR - http://www.scopus.com/inward/record.url?scp=84937558548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937558548&partnerID=8YFLogxK

U2 - 10.1089/hum.2015.091

DO - 10.1089/hum.2015.091

M3 - Review article

VL - 26

SP - 413

EP - 424

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 7

ER -